S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

BLUE bluebird bio Inc

0.915

0.0057 (0.63%)

After Hours

Last Updated: 09:20:54

Delayed by 15 minutes

Bristol Myers and Bluebird bio win FDA approval for ide-cel in multiple myeloma

To read the full story on Seeking Alpha, click here.

bluebird bio (NASDAQ:BLUE)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more bluebird bio Charts.

bluebird bio (NASDAQ:BLUE)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more bluebird bio Charts.

Bluebird Bio Inc News

bluebird bio Announces Receipt of Expected Notice from Nasdaq
Saturday 27 April 2024 (6 days ago) • Business Wire

BLUE LAWSUIT ALERT: The Gross Law Firm Notifies bluebird bio, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
Friday 26 April 2024 (7 days ago) • PR Newswire (US)

bluebird bio, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - BLUE
Friday 19 April 2024 (2 weeks ago) • PR Newswire (US)

Class Action Filed Against bluebird bio, Inc. (BLUE) Seeking Recovery for Investors - Contact The Gross Law Firm
Tuesday 16 April 2024 (2 weeks ago) • PR Newswire (US)

Shareholders that lost money on bluebird bio, Inc.(BLUE) Urged to Join Class Action - Contact The Gross Law Firm to Learn More
Friday 12 April 2024 (3 weeks ago) • PR Newswire (US)

bluebird bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Thursday 11 April 2024 (3 weeks ago) • Business Wire

bluebird bio, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before May 28, 2024 to Discuss Your Rights - BLUE
Tuesday 9 April 2024 (3 weeks ago) • PR Newswire (US)

Shareholders that lost money on bluebird bio, Inc.(BLUE) should contact The Gross Law Firm about pending Class Action - BLUE
Friday 5 April 2024 (4 weeks ago) • PR Newswire (US)

bluebird bio Reports Fourth Quarter and 2023 Annual Results and Highlights Operational Progress and 2024 Guidance
Tuesday 26 March 2024 (1 month ago) • Business Wire

bluebird bio to Host Fourth Quarter and 2023 Annual Results Conference Call
Tuesday 26 March 2024 (1 month ago) • Business Wire

bluebird bio Secures up to $175 Million Debt Financing with Hercules Capital
Monday 18 March 2024 (1 month ago) • Business Wire

bluebird bio Announces First Outcomes-Based Agreement with Medicaid for Sickle Cell Disease Gene Therapy
Monday 11 March 2024 (2 months ago) • Business Wire

More Bluebird Bio Inc News Articles

Sterling vs AUD

Australian SE All Ordina...

JP Morgan Chase

Westpac Banking

Verizon Communications

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions